Newsletter

Subscribe and receive updates on this company

Text STOCKS to 72727 for mobile alerts

We are excited to present Bio-AMD, Inc. (OTC: BIAD).

Full DD Report for BIAD

Recent News from (OTC: BIAD)

Bio-AMD, Inc. Second Quarter Update
DARESBURY, UNITED KINGDOM--(Marketwired - Aug 16, 2016) -  Bio-AMD, Inc. and Bio-AMD UK Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") ( OTCQB : BIAD ) here provides a second quarter update. COAG Following withdrawal of a ...
Source: Marketwired
Date: August, 16 2016 08:30
Bio-AMD, Inc. Restructuring, MIDS Project Commences
DARESBURY, UNITED KINGDOM--(Marketwired - Jun 21, 2016) - Bio-AMD, Inc. and Bio-AMD UK Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") ( OTCQB : BIAD ) here provides an update on our MIDS project and a restructuring of our medical dev...
Source: Marketwired
Date: June, 21 2016 08:00
Bio-AMD, Inc.; COAG PT/INR Point of Care Hemostasis Project & Patent Update
DARESBURY, UNITED KINGDOM--(Marketwired - May 12, 2016) - Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") ( OTCQB : BIAD ) here provides an update on its PT/INR COAG project and on other matters around its bu...
Source: Marketwired
Date: May, 12 2016 08:00
Bio-AMD, Inc.; COAG PT/INR Point of Care Hemostasis Project & Patent Update
Bio-AMD, Inc.; COAG PT/INR Point of Care Hemostasis Project & Patent Update
Source: OTC Markets
Date: May, 12 2016 00:00
Bio-AMD, Inc.: MIDS Patent Grant in People's Republic of China
DARESBURY, UNITED KINGDOM--(Marketwired - Mar 3, 2016) - Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company") ( OTCQB : BIAD ) is pleased to confirm that it has received a Certificate of Grant of a patent in the P...
Source: Marketwired
Date: March, 03 2016 08:30
Bio-AMD, Inc.: First MIDS Patent Grant Likely, Shareholder Update
DARESBURY, ENGLAND / ACCESSWIRE / January 11, 2016 / Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company" OTCQB: BIAD) is pleased to provide an update on progress for shareholders. We believe our strategy and appr...
Source: ACCESSWIRE IA
Date: January, 11 2016 08:30
Bio-AMD, Inc.; United States Patent Granted for PT/INR Technology
LONDON, ENGLAND / ACCESSWIRE / July 16, 2015 / Bio-AMD, Inc. and Bio-AMD Holdings Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company") (OTCQB: BIAD), is pleased to announce that it has recently received formal notice of a grant of a United States Pa...
Source: ACCESSWIRE IA
Date: July, 16 2015 08:45
Bio-AMD, Inc.; Ethics Approval for Patient Testing Study
LONDON, ENGLAND, UK /ACCESSWIRE / July 2, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD", "We" or the "Company") (OTCQB: BIAD), is pleased to announce it has obtained a "favourable ethical opinion" from the Nor...
Source: ACCESSWIRE IA
Date: July, 02 2015 08:46
Bio-AMD, Inc.; MIDS Proof of Market Report
FLONDON, ENGLAND / ACCESSWIRE / June 1, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company") (OTCQB: BIAD), is pleased to announce that it has recently received an independent Proof of Market ...
Source: ACCESSWIRE IA
Date: June, 01 2015 08:35
Bio-AMD, Inc.; Implementation of ISO9001 and ISO 13485 Quality Standards
LONDON, ENGLAND / ACCESSWIRE / May 21, 2015 / Bio-AMD, Inc. and Bio Alternative Medical Devices Ltd., our majority owned medical devices subsidiary (together "Bio-AMD," "We" or the "Company" OTCQB: BIAD) is pleased to announce that it is to formalise implementation of the International Organ...
Source: ACCESSWIRE IA
Date: May, 21 2015 08:45

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-04-21N/A0.0095N/AN/A0
2018-04-20N/A0.0095N/AN/A0
2018-04-19N/A0.0095N/AN/A0
2018-04-18N/A0.0095N/AN/A0
2018-04-170.00950.00950.00950.0095100

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-04-17100100100.0000Short
2018-04-13100100100.0000Short
2018-04-1111100.0000Short
2018-04-1010,00020,00050.0000Short
2018-04-03298,428448,42866.5498Short

* Short Mode

Short Analysis provided by Squeeze Report.


About Bio-AMD, Inc. (OTC: BIAD)

Logo for Bio-AMD, Inc. (OTC: BIAD)

Bio AMD is a developer of medical Point of Care diagnostic technologies for application in near patient devices. We have a PT/INR Coagulation meter technology COAG . In addition, we have developed a semi quantitative Digital Strip Reader DSR and are now developing a fully quantitative Magnetic Immunoassay Detection System MIDS .

 

Contact Information

 

 

Current Management

  • David Miller / Interim CFO
  • Tom Barr / CEO
  • David Miller / Chairman

Current Share Structure

  • Market Cap: $960,898 - 03/16/2018
  • Authorized: 500,000,000 - 04/19/2017
  • Issue and Outstanding: 45,975,966 - 04/19/2017
  • Float: 44,923,584 - 04/19/2017

 


Recent Filings from (OTC: BIAD)

Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: March, 31 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: February, 06 2017
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: December, 09 2016
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: November, 15 2016
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: November, 15 2016
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: August, 15 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: June, 20 2016
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: May, 23 2016
Notification that form 10-Q will be submitted late
Filing Type: NT 10-QFiling Source: edgar
Filing Date: May, 17 2016
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 22 2016

 

 


Daily Technical Chart for (OTC: BIAD)

Daily Technical Chart for (OTC: BIAD)


Stay tuned for daily updates and more on (OTC: BIAD)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (OTC: BIAD)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

Monsta Trader
@MonstaTrader

 

 


Disclaimer: Monsta Trader publishes reports providing information on selected companies. Monsta Trader is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. Monsta Trader accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in BIAD is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. Monsta Trader has received up to $100,000 worth of crypto currency from a non-affiliated third party for the publication and circulation of this report. Monsta Trader does not own any shares of BIAD and does not buy, sell, or trade any shares of BIAD. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2016 by Monsta Trader. All rights reserved. Our Full Disclaimer: http://monstatrader.com/disclaimer/

 

 

Release this Report to Investors

Via Email

Via Text

Important

If you would like to schedule the release please Contact Us and we will assist you otherwise we will release this report to investors 15 minutes after payment is received to allow the most current information to be updated before the report is sent. Interested in reaching more investors? Contact Us